The Deep Sedation for Ablation Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT03844841
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT03844841
-
- Other papers using this trial's data
- Electrophysiological differences of randomized deep sedation with dexmedetomidine versus propofol
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03844841. Randomized; single masking; primary purpose treatment. Start 2019-07-01 (actual); primary completion 2020-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Deep Sedation for Ablation Study
- Condition
- Atrial Fibrillation
- Condition
- Ablation
- Condition
- Sedation
- Condition
- Propofol
- Condition
- Dexmedetomidine
- Intervention (Drug)
- Propofol
- Intervention (Drug)
- Dexmedetomidine
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
Record details
- Record id
cardio:ct-nct03844841- Content hash
c94ea889756b454baadcf0a441025fa86a66dd76a0a0cb249ae5938728898908